Navigation Links
New Analysis Shows Troubling Trend in Triglyceride Levels May Be Linked to Rising Rates of Obesity
Date:11/9/2008

While LDL control has improved, there is an urgent need for more comprehensive lipid control to protect against heart disease

NEW ORLEANS, Nov. 9 /PRNewswire/ -- A new 30-year analysis of the National Health and Nutrition Examination Survey (NHANES) database conducted by the National Lipid Association (NLA) indicates that while Americans are doing a better job of managing LDL or "bad" cholesterol, the percentage of adults with high triglycerides, a blood fat linked to heart disease, has doubled, leaving many people at risk for potentially life-threatening events such as heart attack or stroke. Results of the analysis were presented today at the American Heart Association's Annual Scientific Sessions in New Orleans.

Between 1976 and 2006 the number of Americans with unhealthy isolated LDL levels dropped from 43 percent to 40 percent, an improvement that researchers attribute to more aggressive educational initiatives and treatment. However, far less emphasis has been placed on controlling triglycerides. The rising rates of isolated high triglycerides seen over the last three decades underscore the need for physicians and patients to understand and treat all three key lipids, which include LDL, HDL or "good" cholesterol and triglycerides.

"Studies have shown that unhealthy levels of triglycerides and HDL can lead to heart attack and stroke," said study author Jerome D. Cohen, M.D., chairman of the National Lipid Association's consumer affairs committee and professor emeritus of internal medicine and cardiology at the St. Louis University School of Medicine. "As we continue our efforts to reduce the toll of heart disease in America, this study clearly shows the need for increased focus on controlling triglycerides, in addition to the other components of the lipid profile."

Along with LDL and HDL, triglycerides are the third component of the lipid profile and are an independent and compounding risk factor for heart disease, the leading cause of death in the U.S. Studies have shown that the risk of developing heart disease doubles when triglyceride levels are above 200 mg/dL. When triglycerides are above 200 mg/dL and HDL is below 40 mg/dL, a person is at four times the risk of developing heart disease. Other studies have shown that low HDL is predictive of cardiovascular events even when LDL is at goal.

While the percentage of the population with unhealthy HDL levels has remained relatively consistent over the past 30 years, the percentage of adults with a combination of high triglycerides and low levels of HDL doubled from two to four percent, further highlighting the need to simultaneously treat multiple lipids.

Obesity, Age and Triglycerides

The analysis cited dramatic increases in the number of obese Americans as one possible explanation for the spike in triglycerides over the last three decades. Data indicate a strong correlation between obesity (defined as a BMI greater than or equal to 30 kg/m2) and high triglycerides. Rates of obesity more than doubled from 15 percent in 1976 to 33.7 percent in 2006, while the percentage of Americans with isolated high triglycerides also doubled from 2.4 to 5.5 percent.

The study also revealed a strong increase in elevated triglyceride levels among people over the age of 60, with the likelihood of having unhealthy triglycerides increasing nearly five-fold from 1.8 percent in 1976 to 8.7 percent in 2006. This extensive analysis provides strong evidence of the connections between age, weight and lipid levels over the last 30 years.

"As Americans age and rates of obesity continue to grow exponentially, it is becoming more important to monitor and manage HDL and triglycerides, along with LDL," said Thomas Bersot, M.D., president of the National Lipid Association. "By elevating the need to address all three lipids, we hope to improve heart health in America."

Conclusions

Researchers involved with the study concluded that based on these findings, physicians and other healthcare professionals should closely monitor patients' triglyceride levels in an effort to improve preventive care. Patients, for their part, should be aware of all three lipids and work with their healthcare professionals to reach optimal lipid levels.

Study Methodology

Adults aged 20 to 74 years who took the blood lipid examination were selected from NHANES II (1976-1980), NHANES III (1988-1994), and NHANES 1999-2006. Adults missing values on total cholesterol, HDL cholesterol or triglycerides were excluded. Where LDL was missing, the Friedewald equation was used to calculate LDL for patients with TG < 400 and the Hattori equation was used to calculate LDL for patients with TG greater than or equal to 400.

Lipid levels were measured for the sample of adults with laboratory data who were examined in the morning and had fasted for 8.5 to 23 hours. High triglycerides and LDL and low HDL levels were characterized in the analysis as non-optimal, defined as greater than or equal to 150 mg/dL for triglycerides, < 40 mg/dL for HDL and greater than or equal to 100 mg/dL for LDL. Obesity was defined as BMI greater than or equal to 30 kg/m2.

This study was conducted by the National Lipid Association and analysis and research were performed by HealthCore, with the support of an independent grant from Abbott Laboratories.

About the National Lipid Association

The National Lipid Association (NLA) is a multidisciplinary non-profit membership association that serves the community of healthcare professionals who manage patients with lipid disorders and cardiovascular disease. The NLA's public health mission is to help reduce deaths related to dyslipidemias. To help consumers better understand and manage lipids the NLA launched the http://www.learnyourlipids.com Web site.


'/>"/>
SOURCE National Lipid Association
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. Trubion Announces Preliminary Analysis of Phase IIb Results With TRU-015 in Rheumatoid Arthritis
2. Oncology Drugs Development Update - Worldwide Markets and Forecasts of Approved EGFr/HEr2 Inhibitors, Treatment Costs, Pathway Analysis, Current and Expanded Clinical Indications, and Novel Agents in Development
3. New Data From Large Safety Analysis of MYCAMINE Shows Favorable Clinical Safety Profile
4. Immtech Announces Interim Analysis in Phase III African Sleeping Sickness Trial
5. Analysis Shows Vernakalant Hydrochloride Injection Increases Conversion to Normal Heart Rhythm in Acute Atrial Fibrillation Patients Treated Within 48 Hours of Onset
6. New Analysis of Study Data Shows That Asacol(R) (Mesalamine) Delivers Rapid Symptom Relief for Ulcerative Colitis Patients
7. A Sociolinguistic Analysis of In-Office Dialogue Reveals Psychiatrists and Parents Have Significantly Different Perceptions on ADHD and Psychiatric Comorbidities
8. Favrille Provides Update on Timing of Analysis from Pivotal Phase 3 Clinical Trial; Reports Third Quarter 2007 Financial Results
9. Results Of VYVANSE(TM) (lisdexamfetamine dimesylate) Effect Size Analysis Presented at Major Scientific Meeting
10. Progen Presents Additional Analysis of Data from PI-88 Phase 2 Liver Cancer Study at American Association for the Study of Liver Diseases
11. Retrospective Analysis Finds That Initiation of Insulin Glargine in Patients With Type 2 Diabetes was Associated With a Lower Incidence Rate of Myocardial Infarction as Compared With NPH Insulin
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... 8, 2016 KEY FINDINGS ... of the market in 2016 and is expected to ... attributed to a large number of surgical procedures that ... largest share in the patient temperature management market.) Patient ... reducing loss of blood during surgeries, lowering the risks ...
(Date:12/8/2016)... Research and Markets has announced the addition ... Adhesion Type, Application, Usability - Forecast to 2025" report to ... , , ... poised to grow at a CAGR of around 3.2% from 2015 ... witnessing include advancements in extracellular microelectrode arrays and intracellular microelectrodes, research ...
(Date:12/8/2016)... 2016  Valeant Pharmaceuticals International, Inc. (NYSE: ... announced positive results from a Phase 3, multicenter ... safety and efficacy of IDP-118 (halobetasol propionate and ... Within the Phase 3 study ... psoriasis, IDP-118 showed statistical significance to vehicle with ...
Breaking Medicine Technology:
(Date:12/9/2016)... (PRWEB) , ... December 09, 2016 , ... ... whiteboard display solutions, proudly announced today that a new solution for Emergency Departments ... fit in the tight space in Emergency Department examination rooms, and with a ...
(Date:12/8/2016)... Cambridge, MA (PRWEB) , ... December 08, 2016 ... ... the Workers Compensation Research Institute (WCRI) officially opened registration today for its ... Place Hotel in Boston, MA . , The theme of the conference is ...
(Date:12/8/2016)... ... December 08, 2016 , ... CURE Media Group, the nation’s leading digital ... aligned with Upstage Lung Cancer in efforts to combat lung cancer, announced CURE Media ... Jr said, “CURE Media Group is honored to team up with Upstage Lung Cancer ...
(Date:12/8/2016)... (PRWEB) , ... December 08, ... ... Presence Suite 10.2 version gives development continuity to its innovative Unified Instance ... channels management capacity. In addition, this new version optimizes the unattended auto-dialing ...
(Date:12/8/2016)... ... December 08, 2016 , ... Today’s patients are encouraged ... in mind, SIGVARIS has created a new line of anti-embolism stockings to help ... provide the benefits of graduated compression when transitioning from recovery to early rehabilitation. ...
Breaking Medicine News(10 mins):